Related Experiment Video
Updated: Aug 27, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Acute Myocarditis Associated With Desmosomal Gene Variants
Enrico Ammirati1, Francesca Raimondi2, Nicolas Piriou3
1De Gasperis Cardio Center, Niguarda Hospital, Milano, Italy.
Insights
Patients with acute myocarditis and desmosomal gene variants face a significantly higher risk of adverse cardiovascular events, including heart failure and arrhythmias. Genetic testing may aid in risk stratification for these patients.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- The cardiovascular risk associated with acute myocarditis (AM) in patients carrying desmosomal gene variants (DGV) is not well-established.
- Understanding this risk is crucial for patient management and prognostication.
Purpose of the Study:
- To determine the risk of major adverse cardiovascular events, including death, ventricular arrhythmias, recurrent myocarditis, and heart failure, in patients with AM and pathogenic or likely pathogenetic DGV.
Main Methods:
- A retrospective international study involving 97 patients with AM across 23 hospitals.
- Patients were categorized into three groups: AM with DGV (DGV[+]), AM with negative genetic testing (DGV[-]), and AM without genetic testing.
- Cardiac magnetic resonance (CMR) was used for diagnosis and reassessment of cardiac function and structure in 86 patients.
Main Results:
- Patients with AM and DGV (primarily DSP variants) showed a significantly higher 5-year incidence of the main endpoint (62.3%) compared to those without DGV (17.5%) or without genetic testing (5.3%) (P < 0.0001).
- This increased risk was primarily driven by myocarditis recurrence and ventricular arrhythmias.
- Follow-up CMR revealed more late gadolinium-enhanced segments in the DGV(+) AM group, indicating greater myocardial scarring.
Conclusions:
- Patients with AM and evidence of DGV experience a higher rate of adverse cardiovascular events than those with AM but without DGV.
- Further prospective research is warranted to evaluate the utility of genetic testing in refining risk stratification for AM patients, particularly those initially assessed as low-risk.
Background:
The risk of adverse cardiovascular events in patients with acute myocarditis (AM) and desmosomal gene variants (DGV) remains unknown.
Objectives:
The purpose of this study was to ascertain the risk of death, ventricular arrhythmias, recurrent myocarditis, and heart failure (main endpoint) in patients with AM and pathogenic or likely pathogenetic DGV.
Methods:
In a retrospective international study from 23 hospitals, 97 patients were included: 36 with AM and DGV (DGV[+]), 25 with AM and negative gene testing (DGV[-]), and 36 with AM without genetics testing. All patients had troponin elevation plus findings consistent with AM on histology or at cardiac magnetic resonance (CMR). In 86 patients, CMR changes in function and structure were re-assessed at follow-up.
Results:
In the DGV(+) AM group (88.9% DSP variants), median age was 24 years, 91.7% presented with chest pain, and median left ventricular ejection fraction (LVEF) was 56% on CMR (P = NS vs the other 2 groups). Kaplan-Meier curves demonstrated a higher risk of the main endpoint in DGV(+) AM compared with DGV(-) and without genetics testing patients (62.3% vs 17.5% vs 5.3% at 5 years, respectively; P < 0.0001), driven by myocarditis recurrence and ventricular arrhythmias. At follow-up CMR, a higher number of late gadolinium enhanced segments was found in DGV(+) AM.
Conclusions:
Patients with AM and evidence of DGV have a higher incidence of adverse cardiovascular events compared with patients with AM without DGV. Further prospective studies are needed to ascertain if genetic testing might improve risk stratification of patients with AM who are considered at low risk.
More Related Videos
Related Concept Videos
Desmosomes
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

